(This Feb 6. story has been corrected to show the damages are according to an expert report, and not estimated by IHH's unit.

Daiichi Sankyo announced that Hiroyuki Okuzawa will serve as its new CEO starting on April 1, 2025. 1 The previous CEO, Sumao ...

IHH Healthcare Bhd’s share price on Bursa Malaysia edged higher in early trading after its unit Northern TK Venture Pte Ltd ...

Daiichi Sankyo Company, Ltd (TSE: 4568) has appointed Hiroyuki Okuzawa, 62, to succeed Sunao Manabe, DVM, Ph.D. as Chief ...

Northern TK Venture Pte Ltd, IHH Healthcare's Singaporean arm, has raised its claim against Daiichi Sankyo in Tokyo for ...

The Japanese pharma had one asset rejected by the FDA and withdrew a regulatory application for another, but already this ...

Daiichi Sankyo has announced that Hiroyuki Okuzawa will succeed Sunao Manabe as its CEO from 1 April 2025. The company's ...

Malaysia’s IHH Healthcare is seeking up to Rs 10,930 crore ($1.25 billion) in damages from Japan’s Daiichi Sankyo for its ...

The company had initially claimed 20 billion yen ($130.99 million) that Daiichi was ordered to pay as damages to NTK in ...

Tokyo: Daiichi Sankyo Company, Ltd has appointed Hiroyuki Okuzawa, 62, to succeed Sunao Manabe, DVM, Ph.D. as Chief Executive ...

IHH Healthcare seeks ₹10,930 crore compensation from Daiichi Sankyo for Fortis Healthcare stake buy legal dispute.

IHH Healthcare said on Thursday its unit submitted an expert report to a Tokyo court which states damages sought from Japan's ...